Huy N. Trinh

7.3k total citations
104 papers, 2.5k citations indexed

About

Huy N. Trinh is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Huy N. Trinh has authored 104 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Epidemiology, 91 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in Huy N. Trinh's work include Hepatitis C virus research (84 papers), Liver Disease Diagnosis and Treatment (83 papers) and Hepatitis B Virus Studies (83 papers). Huy N. Trinh is often cited by papers focused on Hepatitis C virus research (84 papers), Liver Disease Diagnosis and Treatment (83 papers) and Hepatitis B Virus Studies (83 papers). Huy N. Trinh collaborates with scholars based in United States, United Kingdom and Taiwan. Huy N. Trinh's co-authors include Mindie H. Nguyen, Ruel T. Garcia, Huy Nguyen, Khanh K. Nguyen, Nghiem B. Ha, Brian S. Levitt, Emmet B. Keeffe, Nghi B. Ha, Nghia Nguyen and An K. Le and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Huy N. Trinh

100 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huy N. Trinh United States 31 2.2k 2.0k 302 171 83 104 2.5k
Marie–Pierre Ripault France 20 2.2k 1.0× 2.2k 1.1× 131 0.4× 91 0.5× 87 1.0× 34 2.5k
Rami Moucari France 26 2.5k 1.1× 2.6k 1.3× 184 0.6× 234 1.4× 125 1.5× 49 2.9k
Yılmaz Çakaloğlu Türkiye 26 3.4k 1.6× 3.4k 1.7× 260 0.9× 210 1.2× 62 0.7× 83 3.8k
Alnoor Ramji Canada 21 1.2k 0.5× 1.2k 0.6× 168 0.6× 192 1.1× 51 0.6× 82 1.4k
Chris Kassianides South Africa 16 1.4k 0.6× 1.5k 0.7× 213 0.7× 134 0.8× 19 0.2× 29 1.9k
Eva Martínez‐Bauer Spain 13 1.4k 0.6× 1.4k 0.7× 72 0.2× 263 1.5× 33 0.4× 39 1.7k
Kuo‐Chin Chang Taiwan 24 947 0.4× 877 0.4× 200 0.7× 328 1.9× 40 0.5× 82 1.4k
Hans Hsienhong Lin Taiwan 21 951 0.4× 839 0.4× 113 0.4× 127 0.7× 44 0.5× 53 1.2k
Mauro Viganò Italy 27 2.4k 1.1× 2.2k 1.1× 285 0.9× 160 0.9× 48 0.6× 131 2.9k
Sabela Lens Spain 26 2.1k 1.0× 2.4k 1.2× 237 0.8× 205 1.2× 29 0.3× 119 2.7k

Countries citing papers authored by Huy N. Trinh

Since Specialization
Citations

This map shows the geographic impact of Huy N. Trinh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huy N. Trinh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huy N. Trinh more than expected).

Fields of papers citing papers by Huy N. Trinh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huy N. Trinh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huy N. Trinh. The network helps show where Huy N. Trinh may publish in the future.

Co-authorship network of co-authors of Huy N. Trinh

This figure shows the co-authorship network connecting the top 25 collaborators of Huy N. Trinh. A scholar is included among the top collaborators of Huy N. Trinh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huy N. Trinh. Huy N. Trinh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trinh, Huy N., et al.. (2025). Long-Term Outcomes of Autologous Breast Reconstruction with or without Post-Mastectomy Radiotherapy. Asian Pacific Journal of Cancer Prevention. 26(8). 3103–3109.
2.
3.
Tran, Khanh V., Huy N. Trinh, Hung Van Hoang, et al.. (2024). Experience of Autologous Immunotherapy for Non-Small Cell Lung Cancer Using Zoledronate-Actived Gammadelta T Cells. Clinical Laboratory. 70(01/2024). 1 indexed citations
4.
5.
Moon, Andrew M., Stephanie Watkins, Anna S. Lok, et al.. (2020). Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. Digestive Diseases. 39(3). 247–257. 17 indexed citations
6.
Nguyen, Vy H., An K. Le, Huy N. Trinh, et al.. (2018). Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices. Clinical Gastroenterology and Hepatology. 17(5). 957–967.e7. 27 indexed citations
7.
Nguyen, Emily, Sam Trinh, Huy N. Trinh, et al.. (2018). Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Alimentary Pharmacology & Therapeutics. 49(1). 99–106. 12 indexed citations
8.
Nguyen, Mindie H., Huy N. Trinh, Son Do, et al.. (2017). Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients. The American Journal of Gastroenterology. 112(12). 1824–1831. 17 indexed citations
9.
Hoang, Joseph, Hwai‐I Yang, An K. Le, et al.. (2016). Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine. 95(31). e4433–e4433. 35 indexed citations
10.
Lok, Anna S., Calvin Q. Pan, Steven-Huy Han, et al.. (2016). Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. Journal of Hepatology. 65(3). 509–516. 141 indexed citations
11.
Nguyen, Nghia, Lily H. Kim, Huy N. Trinh, et al.. (2015). Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterology. 2(1). e000060–e000060. 13 indexed citations
12.
Kim, Lily H., et al.. (2015). Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. European Journal of Gastroenterology & Hepatology. 27(8). 871–876. 5 indexed citations
13.
Fung, Scott, Stuart C. Gordon, Zahary Krastev, et al.. (2014). Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml). Liver International. 35(2). 422–428. 4 indexed citations
14.
Wong, Carrie R., et al.. (2013). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. Journal of Clinical Gastroenterology. 48(7). 644–649. 21 indexed citations
15.
Nguyen, Nghia, et al.. (2013). Treatment Eligibility of Patients With Chronic Hepatitis B Initially Ineligible for Therapy. Clinical Gastroenterology and Hepatology. 11(5). 565–571. 20 indexed citations
16.
Berg, Thomas, Fabien Zoulim, Bernd Moeller, et al.. (2013). Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. Journal of Hepatology. 60(4). 715–722. 60 indexed citations
17.
Ha, Nghiem B., Huy N. Trinh, Ruel T. Garcia, et al.. (2012). High Proportion of Hepatitis C Virus in Community Asian American Patients With Non–Liver-related Complaints. Journal of Clinical Gastroenterology. 47(4). 367–371. 14 indexed citations
18.
19.
Wong, Carrie R., Ruel T. Garcia, Huy N. Trinh, et al.. (2009). Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting. Digestive Diseases and Sciences. 54(12). 2712–2721. 56 indexed citations
20.
Garcia, Ruel T., Long H. Nguyen, Huy N. Trinh, et al.. (2008). Prevalence of Colorectal Neoplasms in Asian Americans. Digestive Diseases and Sciences. 54(1). 160–167. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie–Pierre Ripault Breakdown of academic impact, for papers by Rami Moucari Breakdown of academic impact, for papers by Yılmaz Çakaloğlu Breakdown of academic impact, for papers by Alnoor Ramji Breakdown of academic impact, for papers by Chris Kassianides Breakdown of academic impact, for papers by Eva Martínez‐Bauer Breakdown of academic impact, for papers by Kuo‐Chin Chang Breakdown of academic impact, for papers by Hans Hsienhong Lin Breakdown of academic impact, for papers by Mauro Viganò Breakdown of academic impact, for papers by Sabela Lens
Rankless by CCL
2026